APA (7th ed.) Citation

DL, F., P, A., JL, G., A, C., K, K., JJ, E., . . . CE, S. (2020). BDNF rs6265 Variant Alters Outcomes with Levodopa in Early-Stage Parkinson's Disease. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 17(4), 1785. https://doi.org/10.1007/s13311-020-00965-9

Chicago Style (17th ed.) Citation

DL, Fischer, et al. "BDNF Rs6265 Variant Alters Outcomes with Levodopa in Early-Stage Parkinson's Disease." Neurotherapeutics : The Journal of the American Society for Experimental NeuroTherapeutics 17, no. 4 (2020): 1785. https://doi.org/10.1007/s13311-020-00965-9.

MLA (9th ed.) Citation

DL, Fischer, et al. "BDNF Rs6265 Variant Alters Outcomes with Levodopa in Early-Stage Parkinson's Disease." Neurotherapeutics : The Journal of the American Society for Experimental NeuroTherapeutics, vol. 17, no. 4, 2020, p. 1785, https://doi.org/10.1007/s13311-020-00965-9.